Evidence map›Paper›PMID 28694035›Full record

ArticleJournal of thoracic oncology : official publication of the International Association for the Study of Lung Cancer2017

Assessment of the ITMIG Statement on the WHO Histological Classification and of the Eighth TNM Staging of Thymic Epithelial Tumors of a Series of 188 Thymic Epithelial Tumors.

Alexandra Meurgey, Nicolas Girard, Claire Merveilleux du Vignaux, Jean-Michel Maury, François Tronc, Françoise Thivolet-Bejui, Lara Chalabreysse

Abstract read
PubMed Publisher
In one paragraph

Article in Journal of thoracic oncology : official publication of the International Association for the Study of Lung Cancer, 2017. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 31 papers.

0numbers the graph read from it
0cells of the map it votes in
31citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

31 citing papers in PubMed.

  1. Article
  2. Article
  3. Review
  4. Article
  5. Article
  6. Article
  7. Article
  8. Article
  9. Article
  10. Article
  11. Article
  12. Article
  13. Article
  14. Article
  15. Article
  16. SEOM-GECP-GETTHI Clinical Guidelines for the treatment of patients with thymic epithelial tumours (2021).Clinical & translational oncology : official publication of the Federation of Spanish Oncology Societies and of the National Cancer Institute of Mexico · 2022
    Article
  17. Observational
  18. Thymic tumours and their special features.European respiratory review : an official journal of the European Respiratory Society · 2021
    Review
  19. Narrative review of immunotherapy in thymic malignancies.Translational lung cancer research · 2021
    Review
  20. Impact of the TNM staging system for thymoma.Mediastinum (Hong Kong, China) · 2021
    Article
4 · The record

Corrections and comments

5 · Who and what money

Authors and funding

7 authors.

Alexandra MeurgeyDepartment of Pathology, Louis-Pradel Hospital, Hospices Civils de Lyon, Lyon, France.
Nicolas GirardDepartment of Respiratory Medicine, National Expert Centre for Thymic Malignancies, Cancer Institute of the Hospices Civils de Lyon, Louis-Pradel Hospital, Lyon, France; Lyon University, Claude Bernard Lyon-1 University, Lyon, France. Electronic address: nicolas.girard@chu-lyon.fr.
Claire Merveilleux du VignauxDepartment of Respiratory Medicine, National Expert Centre for Thymic Malignancies, Cancer Institute of the Hospices Civils de Lyon, Louis-Pradel Hospital, Lyon, France.
Jean-Michel MauryLyon University, Claude Bernard Lyon-1 University, Lyon, France; Department of Thoracic Surgery, Louis Pradel Hospital, Hospices Civils de Lyon, Lyon, France.
François TroncLyon University, Claude Bernard Lyon-1 University, Lyon, France; Department of Thoracic Surgery, Louis Pradel Hospital, Hospices Civils de Lyon, Lyon, France.
Françoise Thivolet-BejuiDepartment of Pathology, Louis-Pradel Hospital, Hospices Civils de Lyon, Lyon, France; Lyon University, Claude Bernard Lyon-1 University, Lyon, France.
Lara ChalabreysseDepartment of Pathology, Louis-Pradel Hospital, Hospices Civils de Lyon, Lyon, France; Lyon University, Claude Bernard Lyon-1 University, Lyon, France.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

introductionThymic epithelial tumors (TETs) are rare intrathoracic malignancies that are categorized histologically according to the WHO classification, which was recently updated in 2015 on the basis of a consensus statement of the International Thymic Malignancy Interest Group (ITMIG); at the same time, the standard Masaoka-Koga staging system is scheduled to be replaced by the eighth edition of the TNM staging classification by the American Joint Committee on Cancer/Union for International Cancer Control consortium. Our objectives were to analyze the feasibility of assessing ITMIG consensus major and minor morphological and immunohistochemical criteria and the eighth edition of the TNM staging classification in a routine practice setting.

methodsThis is a single-center study conducted at the Louis-Pradel Hospital of Lyon University, one of the largest centers for TETs in France. Overall, a large surgical series of 188 TETs diagnosed in 181 patients between 2000 and 2014 at our center were analyzed.

resultsThere were 89 men (49%) and 92 women (51%); 57 patients (31%) presented with myasthenia gravis at time of diagnosis. According to the WHO classification, there were nine type A thymomas (5%), 67 type AB thymomas (36%), 19 type B1 thymomas (10%), 46 type B2 thymomas (24%), 27 type B3 thymomas (14%), and 20 thymic carcinomas (11%). ITMIG consensus major criteria were identified in 100% of type A, AB, B1, and B2 thymomas. After restaging according to the eighth edition of the TNM staging classification, there were 127 stage I (84%), three stage II (2%), 17 stage IIIa (11%), no stage IIIb, two stage IVa (1%), and three stage IVb (2%) thymomas. Significant correlation between histological type and stage at diagnosis was maintained after restaging according the TNM classification.

conclusionComprehensive analysis of our well-characterized surgical series of 188 TETs indicates the feasibility and the diagnostic value of the ITMIG consensus statement on WHO histological classification and highlights the major switch in staging when the eighth edition of the TNM staging classification is applied.

Indexed as

AdultAgedAged, 80 and overFemaleHumansMaleMiddle AgedNeoplasms, Glandular and EpithelialNeoplasm StagingThymus NeoplasmsWorld Health OrganizationClassificationHistopathologyStagingThymic carcinomaThymoma

Identifiers

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.